Terms of Use

Last updated: 15 August 2026

1. Website purpose

This website provides general corporate, scientific-intelligence and research-supply information. It is intended for professional and informed industry audiences. It is not an online pharmacy, medical service or consumer health service.

2. Research use only

Any research materials or research vials referenced by Aldevan are presented solely for legitimate laboratory research and analytical use. They are not offered for human or veterinary consumption, diagnosis, treatment, prevention or mitigation of disease.

3. No medical or therapeutic advice

Nothing on this website constitutes medical advice, a therapeutic claim, a recommendation to use a substance, a clinical instruction or a guarantee of research outcome. Visitors must obtain their own scientific, legal, regulatory and safety advice.

4. Product and market information

Product descriptions, documentation, availability, pricing, fulfilment routes and market eligibility may vary by country and by product. Any commercial supply is subject to product-specific review, customer qualification, applicable law and separate written terms.

5. Accuracy and availability

We aim to keep corporate information accurate and current, but information may change without notice. Illustrative records, diagrams and examples are not product listings, certificates of analysis, guarantees or statements of current availability.

6. Intellectual property

Unless stated otherwise, Aldevan names, marks, design elements, copy and website materials belong to Aldevan or its licensors. They may not be copied, adapted, redistributed or used in a way that suggests endorsement without written permission.

7. External links

Regional websites and third-party sources may operate under separate terms and privacy notices. Aldevan is not responsible for the content, availability or practices of external websites.

8. Liability and governing law

The final legal entity, governing law, jurisdiction and limitation-of-liability provisions must be confirmed for the corporate structure and launch market before these terms are published as binding terms.